EN
抗体药类似物
Research Grade Ianalumab
All
TD-HV599016_1.jpg
TD-HV599016_2.jpg
  • CatalogTD-HV599016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsVAY-736,CAS:1929549-92-7
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Ianalumab


Catalog No. TD-HV599016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target BR3, TNFRSF13C, BAFF receptor, BLyS receptor 3, Tumor necrosis factor receptor superfamily member 13C, CD268, B-cell-activating factor receptor, BAFFR, BAFF-R
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q96RJ3
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names VAY-736,CAS:1929549-92-7
Background Ianalumab (VAY-736) is a human, decarboxylated antibody against BAFF-R. Ianalumab can block the interaction between BAFF and BAFF-R and antagonize the apoptosis protection mediated by BAFF. Ianalumab exerts antibody-dependent cytotoxic (ADCC), depending on effector cell activation mediated by immune receptor tyrosine activation motif (ITAM).
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HV599016_1.jpg
SEC-HPLC
 
SEC-HPLC detection for Research Grade Ianalumab.
TD-HV599016_2.jpg
Bioactivity
 
Detects CD268/TNFRSF13C in indirect ELISAs.